| 6/5/2024 | HY | Market Commentary: Wednesday junk deals top $4 billion mark; Herc adds to gains; CSC rally continues
|
| 3/21/2024 | HY | Market Commentary: Ryman Hospitality drives by; Medline, Miter trade at premium; funds lose $2.01 billion
|
| 3/20/2024 | HY | Market Commentary: Medline, Miter price; secondary firm post-Fed; Crescent Energy adds; Altice crumbles post-earnings
|
| 3/20/2024 | HY | New Issue: Medline sells $1 billion five-year secured notes at par to yield 6¼%
|
| 3/20/2024 | HY | Medline talks $1 billion five-year secured notes at 6¼% area yield; pricing Wednesday
|
| 3/19/2024 | HY | Market Commentary: Domestic junk market prices $1 billion; Medline joins calendar, existing notes rise
|
| 3/19/2024 | HY | Medline to price $1 billion five-year secured notes on Wednesday; initial talk mid-6% area
|
| 3/18/2024 | HY | Market Commentary: Landsea joins junk bond calendar; Aston Martin, Vital Energy improve; Hertz lower
|
| 11/28/2022 | HY | Market Commentary: Secondary gives back gains; Carnival under pressure; Medline falls; Wynn Macau lower
|
| 9/26/2022 | HY | Market Commentary: AMC bonds gain on preferred offer; Embarq recovers some losses; Rite Aid declines
|
| 9/16/2022 | HY | Market Commentary: Citrix, Tellurian on deck; NCR plunges in junkland; Medline weaker; Royal Caribbean sinks
|
| 5/23/2022 | HY | Market Commentary: Medline higher; Envision declines; Team Health softens; Bausch up; Transocean better
|
| 5/23/2022 | HY | Market Commentary: Morning Commentary: Junk opens week stronger; athenahealth, Medline bonds trade higher
|
| 4/12/2022 | HY | Market Commentary: Oldcastle on deck in junkland; Medline erases losses; CommScope under pressure
|
| 4/11/2022 | HY | Market Commentary: Primary quiet; selling pressure continues in secondary; Medline hits new low; Vivint under pressure
|
| 1/10/2022 | HY | Market Commentary: Starwood prices; Ciena, Golden Nugget on tap; ZipRecruiter outperforms; Medline under pressure
|
| 10/29/2021 | HY | Market Commentary: Armor clears junk bond market; CA Magnum holds higher; Medline soft; front-end paper sought
|
| 10/14/2021 | HY | Market Commentary: Weatherford upsizes in HY sector; risk-on in secondary; Iliad gains continue; Altice breaks par
|
| 10/4/2021 | HY | Market Commentary: Canpack prices $800 million; Medline tranches cool in heavy supply; Altice pressured
|
| 10/1/2021 | HY | Market Commentary: Domtar prices; Medline tranches mixed; Exeter at a premium; ConvaTec lags in junk secondary
|
| 10/1/2021 | HY | Market Commentary: Morning Commentary: Junk opens unchanged as stocks whipsaw; Domtar notes on deck
|
| 9/30/2021 | HY | New Issue: Medline downsizes to $7 billion, prices notes in secured and unsecured tranches
|
| 9/29/2021 | HY | Medline rejiggers buyout financing, shifting proceeds to secured notes and loans, sets price talk
|
| 9/27/2021 | CLHY | Market Commentary: Medline accelerates deadline; Trace3 price talk surfaces; new issue calendar builds
|
| 9/27/2021 | BKDDHY | S&P rates Medline notes B+, B-
|
| 9/27/2021 | BKDDHY | Fitch rates Mozart notes BB-, B-
|
